Dynavax Technologies Corp. got a two-year grant of $600,000 for the study of autoimmune inflammation.
Berkeley-based Dynavax (NASDAQ: DVAX) got the money as a Small Business Innovation Research, or SBIR, grant. The National Institute of Allergy and Infectious Diseases gave the money.
No comments:
Post a Comment